Journals / İstanbul Medical Journal / 2014 / Cilt: 15 - Sayı: 3

Diabetic and Nondiabetic Coronary Heart Disease with Patient Fibrinogen and Middle Platelet Volume for Atherosclerosis

Diyabetik ve Diyabetik Olmayan Koroner Arter Hastalarında Fibrinojen ve Ortalama Trombosit Hacminin Aterosiklerozdaki Yeri

Pages
161–165
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In conclusion, MPV and fibrinogen values may be independent risk factors of cardiovascular complications for type 2 DM patients and may be suggested as useful markers to follow up patients for progression to coronary artery disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study is to determine the importance of factors, such as mean platelet volume (MPV), fibrinogen, HbA1c, total cholesterol, LDL-cholesterol, HDL-cholesterol, triglyceride, and fasting glucose, on cardiovascular complication processes for type 2 diabetes mellitus patients without coronary artery disease (CAD) and also to compare the relationship between these risk factors.
📊
Key Findings & Data:Methods: For this study, data of 182 patients who with coronary hard disease and diabetes mellitus were retrospectively analyzed.
💡
Conclusion & Impact:Conclusion: In conclusion, MPV and fibrinogen values may be independent risk factors of cardiovascular complications for type 2 DM patients and may be suggested as useful markers to follow up patients for progression to coronary artery disease.
🔬Design:Research Article
📍Scope:2009 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study is to determine the importance of factors, such as mean platelet volume (MPV), fibrinogen, HbA1c, total cholesterol, LDL-cholesterol, HDL-cholesterol, triglyceride, and fasting glucose, on cardiovascular complication processes for type 2 diabetes mellitus patients without coronary artery disease (CAD) and also to compare the relationship between these risk factors. Methods: For this study, data of 182 patients who with coronary hard disease and diabetes mellitus were retrospectively analyzed. The patients were followed up at the Outpatient Clinic of Diabetes of Istanbul Education and Research Hospital between 01.01.2009-31.12.201.The mean age of patients were 63.07±11.24 (40-90) years. 115 (63.2%) patients were male and 67 (36.8%) patients were female. The patients were divided into three groups: group 1: patients who had CAD but no DM (n=59), group 2: patients who had CAD and DM (n=60), and group 3: patients who had DM but no CAD (n=62). Results: 201 The mean age of patients was 63.07±11.24 years; 115 patients were male and 67 were female. The patients were divided into three groups: group 1: patients who had CAD but no DM (n=59), group 2: patients who had CAD and Diabetes Mellitus (DM) (n=60), and group 3: patients who had DM but no CAD (n=62). The mean age of patients in each group was as follows: 64±13, 62±9, and 57±11 years. According of post hoc analyses, the fibrinogen and MPV values of group 3 were lower than group 1 and group 2. There was a statistical difference between the groups in terms of mean values of total cholesterol, LDL-cholesterol, HbA1c, and the median values of fasting glucose and triglyceride. There was no difference between the 3 groups in terms of mean values of HDL-cholesterol. Conclusion: In conclusion, MPV and fibrinogen values may be independent risk factors of cardiovascular complications for type 2 DM patients and may be suggested as useful markers to follow up patients for progression to coronary artery disease.

Özet

Amaç: Koroner arter hastalığı olmayan tip 2 diyabetik hastalarda ortalama trombosit hacmi (OTH) ve fibrinojen düzeyleri ile HbA1c, total kolesterol, low density lipoprotein (LDL)-Kolesterol, high density lipoprotein (HDL)-Kolesterol, trigliserit ve açlık kan şekeri düzeyinin kardiovaskuler komplikasyon gelişimindeki önemini araştırmak ve bu risk faktörlerinin birbirleriyle olan ilişkilerini karşılaştırmayı amaçladık. Yöntemler: Çalışmada 1.1.2009-31.12.2011 tarihlerinde İstanbul Eğitim ve Araştırma Hastanesi Diyabet Polikliniğine başvuran ve takip edilen Tip 2 diyabetes mellitus ve koroner arter hastalığı (KAH) olan 182 hastanın dosyaları retrospektif olarak incelendi. Olguların yaşları ortalama 63,07±11,24 (40-90) ve 115'i erkek (%63,2), 67'si (%36,8) kadındı. Hastalar 3 grupta incelendi. Grup 1: KAH olan ve Diabetes Mellitus (DM) olmayan hastalar (n=59), Grup 2: KAH ve DM olan hastalar (n=60), Grup 3: DM olan ve KAH olmayanlar (n=62). Bulgular: Grupların ortalama yaşları sırasıyla; 64±13, 62±9, 57±10 yıl idi. Post hoc analizde Grup 3'ün grup 2 ve 1'e oranla fibrinojen ve OTH değerleri anlamlı olarak düşük saptandı. Gruplar arasında total kolesterol, LDL kolesterol ve HbA1c ortalama değerleri ile açlık kan şekeri (AKŞ) ve trigliserit ortanca değerlerinde istatistiksel önemde anlamlı farklı saptandı. HDL kolesterol ortalama değerlerinde gruplar arasında anlamlı farklılık görülmedi. Sonuç: OTH ve fibrinojenin koroner arter hastalığı olmayan Tip 2 diyabetik hastalarda kardiyovasküler komplikasyon gelişimi için bağımsız risk faktörleri olabileceği ve hastaların koroner arter hastalığı için takibinde kullanılabilecek bir belirteç olarak kabul edilebileceği düşünülmüştür.

🔖

Cite This Article

HACIOĞLU, M. B., ERDENEN, F., MÜDERRİSOĞLU, C., ÜLGEN, E., GÜLDAL, E. A. (2022). Diabetic and Nondiabetic Coronary Heart Disease with Patient Fibrinogen and Middle Platelet Volume for Atherosclerosis. İstanbul Medical Journal, Cilt: 15 - Sayı: 3, 161–165. https://ajindex.com/articles/552233

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Kristensen SD. The platelet-vessel wall interaction in experimental at- herosclerosis and ischaemic heart fdisease with special reference to thrombopoiesis. Dan Med Bull 1992; 39: 110-27.
  2. Endler G, Klimesch A, Sunder-Plassman H, Schillinger M, Exner M, et al. Mean platelet volume is an independent risk factor for myocardial infarction but not for coranary artery disease. Br J Haemotol 2002; 117: 399-404. [CrossRef] Bath PM, Butterworth RJ. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996; 7: 157-61. [CrossRef] Sharp DS, Benowitz NL, Bath PM, Martin JF, Beswick AD, Elwood PC. Cigarette smoking sensitizes and desensitizes impedance- measured ADP-induced platelet aggregation in whole blood. Thromb Haemost 1995; 74: 730-5. Rosenson RS. Myocardial injury, the acute phase response and lipop- rotein metabolism. Am J Coll Cardiol 1993; 22: 933-40. [CrossRef] Folsom AR, Qamhieh HT, Flack JM, et al. Plasma fibrinogen: Levels and correlates in young adults. The coronary artery risc development in young adults (CARDIA) study. Am J Epidemiol 1993; 138: 1023-6.
  3. Zipes DP, Libby P, Bonow RO, Braunwald E. Braunwald's Heart disease A textbook of cardiovascular medicine 7th edition. Elsevier Saunders. Philadelphia 2005: 1355-266.
  4. Willa AH, Moore L, Bryer-Ash M. Contemporary diagnosis of and ma- nagement of type 2 diabetes. (Çev.Ed:Karpuz H, Handbooks in health care Co. Avrupa tıp Kitapçılık, 4004. 9. Kawata R, Ymakido M. Diabetes mellitus and its vascular complications in Japa- nese migrants on the Island Hawaii. Diabetes Care 1979; 2: 161-70. [CrossRef] Waller BF, Pulombo PJ, Lie JT, Roberts WC. Status of coronary arteries at necropsy in diabetes mellitus after age 30 years: Anatysis of 229 diabetic patiendt with and without evidence of coronary heart disease and com- parison to 183 control subjects. Am J Med 1980; 69: 498-506. [CrossRef] The diabetes control and complications trial research group. The effect of intensive treatmebt of diabetes on the development and progression of long term complications in insulin dependent diabe- tes mellitus. N Eng J Med 1993; 329: 977-86. [CrossRef] Donahue RP, Orchard TG. Diabetes mellitus and macrovascular complications: An epidemiological perspective. Diabetes care 1992; 15: 1141-55. [CrossRef] Crub JD, Rodriguez BL. Sudden death, impair glucose tolerance and diabetes in Japanese American men. Circulation 1995; 91: 2591-5. [CrossRef] Kültürsoy H. Lipit düşürücü tedavi Koroner Kalp Hastalığı